Trends in Nanomedicine (TechVision)

Trends in Nanomedicine (TechVision)

Nano-based science paving the precision medicine era

RELEASE DATE
30-Dec-2015
REGION
Global
Research Code: D6C0-01-00-00-00
SKU: HC02409-GL-TR_16531
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02409-GL-TR_16531

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

The continued development of new treatments associated with the demographic trends and public health considerations is remarkable. Nanotechnology has been identified as one most relevant key enabling technologies of the last ten years, significantly impacting on many different biomedical developments in a broad spectrum of applications therapeutics, diagnostics, theranostics, medical imaging, regenerative medicine, life sciences research and biosciences, among many others. In fact, nanomedicine is present in all therapeutic areas, exhibiting a perceptible and extensive impact in the treatment and diagnosis of some most concerned diseases.

Innovation in nanomedicine fields has played a major role in the improvement of both length and quality of life during the present decade, appreciably advocated to reduce the disease burden for individuals and the society through completely new or improved diagnostic and therapeutic methods. Groundbreaking advances in the scientific understanding of the underlying mechanisms of disease are paving the way for nanomedicine on precision medicine topics.

Frost & Sullivan (www.frost.com/techvision) identified an unprecedented behavior in terms of innovation in nanomedicine fields, with notable acceptance in diagnostics, therapeutics, companion diagnostics, regenerative medicine, and many other applications that are undoubtedly linked to the concept of precision medicine. Nanomedicine enables personalized medicine approaches in many ways. As an instance, nano-based diagnostic tests or nano-imaging diagnosis may help to the stratification of patients and thereby to guarantee a most personalized, patient-centered therapy. In addition, clinical protocols become simpler, more efficient and less costly.

Table of Contents

Research Scope

Research Scope (continued)

Research Methodology

Key Findings

Industry Value Chain and Business Model

Core Technology Applications

Technology Evolution

Core Growth Opportunities

Technology Synergy and Nanobiotechnology

Technology Roadmap

Industry Drivers and Restraints

Industry Technical and Business Challenges

Market Drivers and Restraints

Technology Drivers and Restraints

Porter’s Five Forces Analysis

Nanomedicine Innovation Model

Nanomedicine Innovation Model (continued)

Nanomedicine Innovation Model (continued)

Nanomedicines Application Focus

Nanomedicines Therapeutics Focus

Nanomedicines Diagnostics Focus

Nanomedicines Regenerative Medicine Focus

Nanomedicine Multiple Segmentation

Nanomedicines Principal Industry Facts

Nanomedicines Principal Industry Facts (continued)

Nanomedicine Development Pipeline

Nanomedicine Products by Developmental Phase

Global Nanomedicine Market

Global Nanomedicine Market (continued)

Global Nanomedicine Market (continued)

Product Pipeline

Product Pipeline (continued)

Product Pipeline (continued)

Product Pipeline (continued)

Product Pipeline (continued)

Product Pipeline (continued)

Nanomedicine Marketed Products

Nanomedicine Marketed Products (continued)

Nanomedicine Marketed Products (continued)

Key Companies in North America

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in North America (continued)

Key Companies in Europe

Key Companies in Europe (continued)

Key Companies in Europe (continued)

Key Companies in Europe (continued)

Key Companies in Europe (continued)

Key Companies in Europe (continued)

Key Companies in Europe (continued)

Key Companies in Asia Pacific

Key Companies in Asia Pacific (continued)

Intellectual Property

Intellectual Property (continued)

Intellectual Property (continued)

Multicriteria Approach for Benchmarking

Multicriteria Approach for Benchmarking (continued)

Multicriteria Approach for Benchmarking (continued)

Multicriteria Approach for Benchmarking (continued)

Multicriteria Approach for Benchmarking (continued)

Multicriteria Approach for Benchmarking (continued)

Multicriteria Approach for Benchmarking (continued)

Multicriteria Approach for Benchmarking (continued)

Multicriteria Approach for Benchmarking (continued)

Final Remarks

Legal Disclaimer

Key Contacts

Key Contacts (continued)

Key Contacts (continued)

Key Contacts (continued)

Key Contacts (continued)

Key Contacts (continued)

Key Contacts (continued)

Intellectual Property Sources

Key Patents

Key Patents (continued)

Key Patents (continued)

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research
The continued development of new treatments associated with the demographic trends and public health considerations is remarkable. Nanotechnology has been identified as one most relevant key enabling technologies of the last ten years, significantly impacting on many different biomedical developments in a broad spectrum of applications therapeutics, diagnostics, theranostics, medical imaging, regenerative medicine, life sciences research and biosciences, among many others. In fact, nanomedicine is present in all therapeutic areas, exhibiting a perceptible and extensive impact in the treatment and diagnosis of some most concerned diseases. Innovation in nanomedicine fields has played a major role in the improvement of both length and quality of life during the present decade, appreciably advocated to reduce the disease burden for individuals and the society through completely new or improved diagnostic and therapeutic methods. Groundbreaking advances in the scientific understanding of the underlying mechanisms of disease are paving the way for nanomedicine on precision medicine topics. Frost & Sullivan (www.frost.com/techvision) identified an unprecedented behavior in terms of innovation in nanomedicine fields, with notable acceptance in diagnostics, therapeutics, companion diagnostics, regenerative medicine, and many other applications that are undoubtedly linked to the concept of precision medicine. Nanomedicine enables personalized medicine approaches in many ways. As an instance, nano-based diagnostic tests or nano-imaging diagnosis may help to the stratification of patients and thereby to guarantee a most personalized, patient-centered therapy. In addition, clinical protocols become simpler, more efficient and less costly.
More Information
No Index No
Podcast No
Author Cecilia Van Cauwenberghe
Industries Healthcare
WIP Number D6C0-01-00-00-00
Keyword 1 Nanomedicine
Keyword 2 Nanomedicine Size
Keyword 3 Nanomedicine Trends
Is Prebook No